# GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

> **NCT01209065** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 27 (actual)

## Conditions studied

- Infections, Human Immunodeficiency Virus and Herpesviridae

## Interventions

- **DRUG:** GSK1349572
- **DRUG:** Fosamprenavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT01209065
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209065, "GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01209065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*